Cargando…
Comment on: “Enzalutamide: A Step Towards Pharmacokinetic-Based Dosing in Men with Metastatic Castration-Resistant Prostate Cancer”
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4712250/ https://www.ncbi.nlm.nih.gov/pubmed/26649871 http://dx.doi.org/10.1007/s40262-015-0350-7 |
| _version_ | 1782410031145156608 |
|---|---|
| author | Gibbons, Jacqueline A. |
| author_facet | Gibbons, Jacqueline A. |
| author_sort | Gibbons, Jacqueline A. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4712250 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2015 |
| publisher | Springer International Publishing |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-47122502016-01-19 Comment on: “Enzalutamide: A Step Towards Pharmacokinetic-Based Dosing in Men with Metastatic Castration-Resistant Prostate Cancer” Gibbons, Jacqueline A. Clin Pharmacokinet Letter to the Editor Springer International Publishing 2015-12-09 2016 /pmc/articles/PMC4712250/ /pubmed/26649871 http://dx.doi.org/10.1007/s40262-015-0350-7 Text en © The Author(s) 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
| spellingShingle | Letter to the Editor Gibbons, Jacqueline A. Comment on: “Enzalutamide: A Step Towards Pharmacokinetic-Based Dosing in Men with Metastatic Castration-Resistant Prostate Cancer” |
| title | Comment on: “Enzalutamide: A Step Towards Pharmacokinetic-Based Dosing in Men with Metastatic Castration-Resistant Prostate Cancer” |
| title_full | Comment on: “Enzalutamide: A Step Towards Pharmacokinetic-Based Dosing in Men with Metastatic Castration-Resistant Prostate Cancer” |
| title_fullStr | Comment on: “Enzalutamide: A Step Towards Pharmacokinetic-Based Dosing in Men with Metastatic Castration-Resistant Prostate Cancer” |
| title_full_unstemmed | Comment on: “Enzalutamide: A Step Towards Pharmacokinetic-Based Dosing in Men with Metastatic Castration-Resistant Prostate Cancer” |
| title_short | Comment on: “Enzalutamide: A Step Towards Pharmacokinetic-Based Dosing in Men with Metastatic Castration-Resistant Prostate Cancer” |
| title_sort | comment on: “enzalutamide: a step towards pharmacokinetic-based dosing in men with metastatic castration-resistant prostate cancer” |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4712250/ https://www.ncbi.nlm.nih.gov/pubmed/26649871 http://dx.doi.org/10.1007/s40262-015-0350-7 |
| work_keys_str_mv | AT gibbonsjacquelinea commentonenzalutamideasteptowardspharmacokineticbaseddosinginmenwithmetastaticcastrationresistantprostatecancer |